I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 8 studies | 36% ± 16% | |
| glutamatergic neuron | 6 studies | 30% ± 11% | |
| interneuron | 4 studies | 51% ± 24% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 8 studies | 36% ± 16% | |
| glutamatergic neuron | 6 studies | 30% ± 11% | |
| interneuron | 4 studies | 51% ± 24% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 36% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 76% | 1817.89 | 1996 / 2642 | 63% | 17.14 | 447 / 705 |
| adrenal gland | 21% | 127.45 | 55 / 258 | 65% | 48.99 | 149 / 230 |
| prostate | 22% | 231.15 | 54 / 245 | 36% | 5.67 | 179 / 502 |
| intestine | 29% | 140.74 | 278 / 966 | 0% | 0.02 | 1 / 527 |
| breast | 0% | 0.32 | 1 / 459 | 22% | 15.59 | 243 / 1118 |
| bladder | 19% | 72.24 | 4 / 21 | 0% | 0.03 | 2 / 504 |
| stomach | 13% | 48.47 | 48 / 359 | 0% | 0.02 | 1 / 286 |
| kidney | 0% | 0 | 0 / 89 | 14% | 6.06 | 123 / 901 |
| thymus | 7% | 21.65 | 45 / 653 | 1% | 0.04 | 4 / 605 |
| pancreas | 0% | 0 | 0 / 328 | 3% | 2.33 | 6 / 178 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.13 | 1 / 80 |
| blood vessel | 1% | 1.48 | 8 / 1335 | 0% | 0 | 0 / 0 |
| esophagus | 0% | 1.41 | 7 / 1445 | 0% | 0 | 0 / 183 |
| ovary | 0% | 0 | 0 / 180 | 0% | 0.01 | 1 / 430 |
| lung | 0% | 0 | 0 / 578 | 0% | 0.01 | 2 / 1155 |
| skin | 0% | 0.34 | 2 / 1809 | 0% | 0 | 0 / 472 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| uterus | 0% | 0 | 0 / 170 | 0% | 0 | 0 / 459 |
| GO_0010628 | Biological process | positive regulation of gene expression |
| GO_0070352 | Biological process | positive regulation of white fat cell proliferation |
| GO_0090336 | Biological process | positive regulation of brown fat cell differentiation |
| GO_0010884 | Biological process | positive regulation of lipid storage |
| GO_0030154 | Biological process | cell differentiation |
| GO_0071773 | Biological process | cellular response to BMP stimulus |
| GO_0005576 | Cellular component | extracellular region |
| GO_0016020 | Cellular component | membrane |
| GO_0005634 | Cellular component | nucleus |
| GO_0042802 | Molecular function | identical protein binding |
| Gene name | VSTM2A |
| Protein name | V-set and transmembrane domain containing 2A V-set and transmembrane domain-containing protein 2A |
| Synonyms | VSTM2 |
| Description | FUNCTION: Plays a role in the regulation of the early stage of white and brown preadipocyte cell differentiation. Promotes adipogenic commitment of preadipocytes by increasing gene expression of the transcription factor PPARG in a BMP4-dependent signaling pathway. . |
| Accessions | ENST00000302287.7 [Q8TAG5-2] ENST00000404951.5 ENST00000402613.4 B5MCX6 ENST00000407838.7 [Q8TAG5-1] F8W8J5 Q8TAG5 |
